Xinhua Li
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2020First federal award
$6.4MFederal grants as PI7 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
7 awards · $6.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 24, 2025 | NIH | SBIR Phase II A Novel Reversal Agent for Treatment of Overdose from the Combination of Fentanyl and Xylazine | $1.5M | Clear Scientific, LLC |
| Aug 1, 2024 | NIH | SBIR Phase II A Novel Reversal Agent for Treatment of Overdose from the Combination of Fentanyl and Xylazine | $1.5M | Clear Scientific, LLC |
| Sep 30, 2022 | NIH | SBIR Phase I An oral therapeutic to treat intoxication by prescription and illicit stimulants | $320K | Clear Scientific, LLC |
| Aug 24, 2022 | NIH | SBIR Phase II Novel Therapeutic Agents to Reverse Opioid Overdose | $1.2M | Clear Scientific, LLC |
| Jun 23, 2022 | NIH | SBIR Phase I A novel therapeutic approach for treatment of acute intoxication by co-use of opioids and stimulants | $320K | Clear Scientific, LLC |
| Sep 22, 2021 | NIH | SBIR Phase II Novel Therapeutic Agents to Reverse Opioid Overdose | $1.3M | Clear Scientific, LLC |
| Sep 30, 2020 | NIH | SBIR Phase I Novel Therapeutic Agents to Reverse Opioid Overdose | $225K | Clear Scientific, LLC |
Peer ranks
Federal funding#181
Awards as PI#280
Patents#505
Companies
- Clear Scientific, LLCLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.